INVESTIGATING THE SAFETY AND EFFICACY, QUALITY OF LIFE, COST-EFFICIENCY AND IMMUNE POTENTIAL OF HIGH PRECISION LUNG RADIOTHERAPY
Grant number: 1082399 | Funding period: 2015 - 2019
Related publications (2)
Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomized Phase II Trial
S Siva, M Bressel, T Kron, T Mai, HV Le, R Montgomery, N Hardcastle, A Rezo, S Gill, BG Higgs, DI Pryor, R De Abreu Lourenco, R Awad, B Chesson, TN Eade, M Skala, G Sasso, W Wong, S Vinod, D Ball
A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)
Shankar Siva, Tomas Kron, Mathias Bressel, Marion Haas, Tao Mai, Shalini Vinod, Giuseppe Sasso, Wenchang Wong, Hien Le, Thomas Eade, Nicholas Hardcastle, Brent Chesson, Daniel Pham, Morten Hoyer, Rebecca Montgomery, David Ball
BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is emerging as a non-invasive method for precision irradiation of lung ..